Gene · 1289
Papers3,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| H3G34-Mutant Gliomas-A Review of Molecular Pathogenesis and Therapeutic Options. | Biomedicines | 2023 | 37509641 | PubTator, text mining | PubMed |
| Small Leucine-Rich Proteoglycan PODNL1 Identified as a Potential Tumor Matrix-Mediated Biomarker for Prognosis and Immunotherapy in a Pan-Cancer Setting. | Curr Issues Mol Biol | 2023 | 37504302 | PubTator, text mining | PubMed |
| A Clinical Qualification Protocol Highlights Overlapping Genomic Influences and Neuro-Autonomic Mechanisms in Ehlers-Danlos and Long COVID-19 Syndromes. | Curr Issues Mol Biol | 2023 | 37504295 | PubTator, text mining | PubMed |
| Therapeutic difficulties in a patient with Ehlers-Danlos syndrome and numerous symptomatic premature ventricular contractions-case report and literature review. | Front Cardiovasc Med | 2023 | 37502188 | PubTator, text mining | PubMed |
| ac4C acetylation regulates mRNA stability and translation efficiency in osteosarcoma. | Heliyon | 2023 | 37484432 | PubTator, text mining | PubMed |
| Lumican is a potential predictor on the efficacy of concurrent chemoradiotherapy in cervical squamous cell carcinoma. | Heliyon | 2023 | 37483824 | PubTator, text mining | PubMed |
| Sequence variants contributing to dysregulated inflammatory responses across keratoconic cone surface in adolescent patients with keratoconus. | Front Immunol | 2023 | 37483635 | PubTator, text mining | PubMed |
| PCDH7 as the key gene related to the co-occurrence of sarcopenia and osteoporosis. | Front Genet | 2023 | 37476411 | PubTator, text mining | PubMed |
| A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape. | Front Oncol | 2023 | 37476379 | PubTator, text mining | PubMed |
| Characteristic impairment of progesterone response in cultured cervical fibroblasts obtained from patients with refractory cervical insufficiency. | Sci Rep | 2023 | 37474547 | PubTator, text mining | PubMed |
| Identification of an ADAMTS2 frameshift variant in a cat family with Ehlers-Danlos syndrome. | G3 (Bethesda) | 2023 | 37462293 | PubTator, text mining | PubMed |
| CHSY3 promotes proliferation and migration in gastric cancer and is associated with immune infiltration. | J Transl Med | 2023 | 37461041 | PubTator, text mining | PubMed |
| A Novel Cell Membrane-Associated RNA Extraction Method and Its Application in the Discovery of Breast Cancer Markers. | Anal Chem | 2023 | 37459193 | PubTator, text mining | PubMed |
| Lineage Plasticity in SCLC Generates Non-Neuroendocrine Cells Primed for Vasculogenic Mimicry. | J Thorac Oncol | 2023 | 37455012 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cells and Exosomes: A Novel Therapeutic Approach for Corneal Diseases. | Int J Mol Sci | 2023 | 37446091 | PubTator, text mining | PubMed |
| Marfan Syndrome: Enhanced Diagnostic Tools and Follow-up Management Strategies. | Diagnostics (Basel) | 2023 | 37443678 | PubTator, text mining | PubMed |
| Candidate genes for obstructive sleep apnea in non-syndromic children with craniofacial dysmorphisms - a narrative review. | Front Pediatr | 2023 | 37441579 | PubTator, text mining | PubMed |
| Osteoarthritis related epigenetic variations in miRNA expression and DNA methylation. | BMC Med Genomics | 2023 | 37434153 | PubTator, text mining | PubMed |
| RUSC1-AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR-326/XRCC5 pathway. | Thorac Cancer | 2023 | 37429610 | PubTator, text mining | PubMed |
| High Prevalence of Collagenopathies in Preterm- and Term-Born Children With Periventricular Venous Hemorrhagic Infarction. | J Child Neurol | 2023 | 37427422 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1289/papers?page=20